HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 386 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 101,211 | $3,866 | 0.01% |
| BANK OF AMERICA CORP /DE/ | 1,190,236 | $45,467,014 | 0.01% |
| NATIXIS ADVISORS, L.P. | 44,820 | $1,712 | 0.01% |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 26,867 | $1,026,319 | 0.01% |
| STEPHENS INC /AR/ | 6,130 | $234,166 | 0.00% |
| CAPTRUST FINANCIAL ADVISORS | 26,403 | $1,008,595 | 0.00% |
| NVWM, LLC | 302 | $11,536 | 0.00% |
| ProShare Advisors LLC | 32,619 | $1,246,046 | 0.00% |
| Boston Partners | 83,415 | $3,185,922 | 0.00% |
| Man Group plc | 35,484 | $1,355,489 | 0.00% |
| AQR Capital Management | 50,263 | $1,920,047 | 0.00% |
| Cubist Systematic Strategies, LLC | 14,500 | $553,900 | 0.00% |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | 5,900 | $225,380 | 0.00% |
| Point72 Asset Management, L.P. | 32,160 | $1,228,512 | 0.00% |
| LGT Financial Advisors LLC | 75 | $2,865 | 0.00% |
| TCTC Holdings, LLC | 2,813 | $107,457 | 0.00% |
| DekaBank Deutsche Girozentrale | 50,000 | $1,950 | 0.00% |
| ENVESTNET ASSET MANAGEMENT INC | 215,405 | $8,228,471 | 0.00% |
| MORGAN STANLEY | 1,034,415 | $39,514,686 | 0.00% |
| EP Wealth Advisors, LLC | 5,516 | $210,711 | 0.00% |
External links
This page lists HALOZYME THERAPEUTICS INC's shareholders in Q3 2023. To view HALOZYME THERAPEUTICS INC's shareholder history, click here.